Radiography
Volume 14, Issue 1 , Pages 2-7 , February 2008

Colorectal carcinoma in a patient with prior breast cancer: Is there a causal link?

  • Elaine Scarles

      Affiliations

    • Blackpool Victoria Hospital, Blackpool, Lancashire FY3 8NR, UK
    • ,
  • Julie Nightingale

      Affiliations

    • Department of Radiography, School of Health Care Professions, University of Salford, Salford, Greater Manchester, M6 6PU, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 161 295 2158.

Received 13 April 2006 ,Accepted 11 August 2006.

References 

  1. Cancer Research UK. Fact sheets: Cancer statistics. http://www.cancerresearchuk.org; 2006 [accessed on 06.04.06].
  2. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Lango DL, Jameson LJ. Harrison's principles of internal medicine, vol. 1. 15th ed.. London: McGraw Hill Medical Publishing Division; 2001;
  3. Emmons KM, McBride CM, Puleo E, Pollak KI, Marcus BH, Napolitano M, et al. Prevalance and predictors of multiple behavioural risk factors for colon cancer. Preventative Medicine. 2005;40:527–534
  4. Cancer Research UK, Fact sheets: Breast cancer symptoms and treatment. http://www.cancerresearchuk.org; 2006 [accessed on 01.04.06].
  5. Kmet LM, Cook LS, Weiss NS, Schwartz SM, White E. Risk factors for colorectal cancer following breast cancer. Breast Cancer Research and Treatment. 2003;79(2):143–147
  6. Cancer Research UK. Fact sheets: Bowel cancer statistics. http://www.cancerresearchuk.org; 2006 [accessed on 06.04.06].
  7. Manjer J, Janzon L. Covariance of breast cancer incidence with smoking-, oestrogen- and diet-related cancers in pre- and postmenopausal women in Sweden. Medical Hypotheses. 1999;52(6):561–568
  8. Russo IH. Cigarette smoking and risk of breast cancer in women. The Lancet. 2002;360:1033–1034
  9. Collaborative Group on Hormonal Factors and Breast Cancer, Alcohol, tobacco, and breast cancer . Collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. British Journal of Cancer. 2002;87:1234–1245
  10. Chaturvedi P. Does smoking increase the risk of breast cancer?. The Lancet Oncology. 2003;657–658
  11. D'Avanzo B, La Vecchia C, Franceschi S, Gallotti L, Talamini R. Cigarette smoking and colorectal cancer: A study of 1,584 cases and 2,879 controls. Preventative Medicine. 1995;24:571–579
  12. Ye YN, Wu WKK, Shin VY, Cho CH. A mechanistic study of colon cancer growth promoted by cigarette smoke extract. European Journal of Pharmacology. 2005;519:52–57
  13. Kenemans P, Verstraeten RA, Verheijen RHM. Postmenopausal hormone therapy and cancer risk. International Congress Series. 2005;1279:133–140
  14. Olsson H, Bladstrom A, Ingvar C. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy?. Obstetrics and Gynaecology. 2003;102(3):565–570
  15. Breast Cancer Org. Five benefits of tamoxifen. http://www.breastcancer.org; 2004 [accessed on 04.04.06].
  16. Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N. Adjuvant Tamoxifen therapy for early stage breast cancer and second primary malignancies. Journal of the National Cancer Institute. 1995;87(9):645–651
  17. Newcomb PA, Solomon C, White E. Tamoxifen and risk of large bowel cancer in women with breast cancer. Breast Cancer Research and Treatment. 1999;53(3):271–277
  18. Cook LS, Weiss NS, Pharris CN, Schwartz SM, White E. Colorectal cancer following tamoxifen therapy for breast cancer. Cancer Causes and Control. 2001;12(5):405–410
  19. Matsuyama Y, Tominaga T, Nomura Y, Koyama H, Kimura M, Sano M. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Annals of Oncology. 2000;11(12):1537–1543
  20. Early Breast Cancer Trialists’ Collaborative Group . Tamoxifen for early breast cancer: an overview of the randomised trials. The Lancet. 1998;351:1451–1467
  21. Nakayama Y, Sakamoto H, Satoh K, Yamamoto T. Tamoxifen and gonadal steroids inhibit colon cancer growth in association with inhibition of thymidylate synthase, surviving and telomerase expression through estrogen receptor beta mediated system. Cancer Letters. 2000;161:63–71
  22. Parham P. The immune system. London, England: Garland Publishing; 2000;
  23. Fasching PA, Nestle-Kramling C, Brumm C, Djahansouzi S, Beckmann MW. Cancer in the family and implications for hormone replacement therapy. International Congress Series. 2002;1229:157–161
  24. Gehrig PA, Bae-Jump VL, Boggess JF, Groben PA, Fowler WC, Van Le L. Association between uterine serous carcinoma and breast cancer. Gynecologic Oncology. 2004;94:208–211
  25. Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P. Second cancers after conservative surgery and radiation for stages I-II breast cancer: Identifying a subset of women at increased risk. International Journal of Radiation Oncology Biology Physics. 2001;51(3):679–690
  26. Ochsenkuhn T, Bayerdorffer E, Meining A, Spath L, Mannes GA, Wiebecke B, et al. Increased prevalence of colorectal adenomas in women with breast cancer. Digestion. 2005;72(2–3):150–155
  27. Srinivasan R, Yang Y, Rubin SC, Morgan MA, Lewis JD. Women with a prior diagnosis of breast cancer are not at an increased risk for subsequent colorectal cancer. American Journal of Gastroenterology. 2005;100(12):2759–2764
  28. Cassidy J, Bissett D, Spence RAJ. Oxford handbook of oncology. Oxford, UK: Oxford University Press; 2002;

PII: S1078-8174(06)00098-8

doi: 10.1016/j.radi.2006.08.002

Radiography
Volume 14, Issue 1 , Pages 2-7 , February 2008

Article Tools

* Image Usage & Resolution